Detection of oligomeric forms of -synuclein protein in human plasma as a potential biomarker for Parkinson's disease
David Allsop, Omar El-agnaf
The FASEB Journal, 2006
View PDFchevron_right
Detection of Oligomeric Forms of {Alpha}-Synuclein Protein In Human Plasma As a Potential Biomarker for Parkinson's Disease
Sultan Salem
The FASEB Journal, 2006
View PDFchevron_right
Development of a Biochemical Diagnosis of Parkinson Disease by Detection of α-Synuclein Misfolded Aggregates in Cerebrospinal Fluid
Nicolas Mendez
JAMA Neurology, 2017
View PDFchevron_right
Plasma α-synuclein is decreased in subjects with Parkinson's disease
Su Mok
Experimental Neurology, 2007
View PDFchevron_right
-Synuclein implicated in Parkinson's disease is present in extracellular biological fluids, including human plasma
David Allsop, Omar El-agnaf
The FASEB Journal, 2003
View PDFchevron_right
Parkinson’s disease biomarkers based on α‐synuclein
Omar El-Agnaf
Journal of Neurochemistry, 2019
View PDFchevron_right
α-Synuclein and DJ-1 as potential biological fluid biomarkers for Parkinson's Disease
Kazunari Sekiyama
International journal of molecular sciences, 2010
View PDFchevron_right
Disease-Associated α-Synuclein Aggregates as Biomarkers of Parkinson Disease Clinical Stage
Ilham Abdi
Neurology
View PDFchevron_right
Alpha-Synuclein as a Biomarker of Parkinson’s Disease: Good, but Not Good Enough
soumya pal
Frontiers in Aging Neuroscience
View PDFchevron_right
Comparative study of cerebrospinal fluid α-synuclein seeding aggregation assays for diagnosis of Parkinson's disease
Graham Fairfoul
Movement Disorders, 2019
View PDFchevron_right
α‐Synuclein in blood cells differentiates Parkinson’s disease from healthy controls
Suaad Elhadi
Annals of Clinical and Translational Neurology, 2019
View PDFchevron_right
DJ-1 and -synuclein in human cerebrospinal fluid as biomarkers of Parkinson's disease
Aneeka Hancock, Kathryn Chung
Brain, 2010
View PDFchevron_right
Quantification of α-synuclein in cerebrospinal fluid: How ideal is this biomarker for Parkinson's disease?
Michael Schlossmacher
2014
View PDFchevron_right
Posttranslational modifications of blood-derived alpha-synuclein as biochemical markers for Parkinson's disease OPEN
Hugo Vicente Miranda
View PDFchevron_right
Biomarkers and the Role of α-Synuclein in Parkinson’s Disease
Tingting Du
Frontiers in Aging Neuroscience, 2021
View PDFchevron_right
Immunochemical Detection of α-Synuclein Autoantibodies in Parkinson's Disease: Correlation between Plasma and Cerebrospinal Fluid Levels
Ludmilla Morozova-Roche
ACS chemical neuroscience, 2017
View PDFchevron_right
In vivo markers of Parkinson’s disease and dementia with Lewy bodies: current value of the 5G4 α-synuclein antibody
Erwin Schleicher
Acta Neuropathologica, 2014
View PDFchevron_right
Posttranslational modifications of blood-derived alpha-synuclein as biochemical markers for Parkinson's disease
Elisa Miranda
Scientific reports, 2017
View PDFchevron_right
Measurements of auto-antibodies to α-synuclein in the serum and cerebral spinal fluids of patients with Parkinson's disease
Leslie Shaw
Journal of neurochemistry, 2018
View PDFchevron_right
In vivo distribution of α-synuclein in multiple tissues and biofluids in Parkinson disease
David G Munoz
Neurology, 2020
View PDFchevron_right
Decreased α-synuclein in cerebrospinal fluid of aged individuals and subjects with Parkinson’s disease
David Allsop, Omar El-agnaf
Biochemical and Biophysical Research Communications, 2006
View PDFchevron_right
Alpha-synuclein implicated in Parkinson's disease is present in extracellular biological fluids, including human plasma
John Hardy
FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2003
View PDFchevron_right
Full length α-synuclein is present in cerebrospinal fluid from Parkinson's disease and normal subjects
Alessandro Negro
Neuroscience Letters, 2000
View PDFchevron_right
Alpha-Synuclein: Biomarker for Parkinson’s Disease, It’s Estimation Methods, and Targeted Medicinal Therapies
vaishali undale
2021
View PDFchevron_right
Streamlined alpha-synuclein RT-QuIC assay for various biospecimens in Parkinson’s disease and dementia with Lewy bodies
Alan Lerner
Acta Neuropathologica Communications, 2021
View PDFchevron_right
alpha-Synuclein Reactive Antibodies as Diagnostic Biomarkers in Blood Sera of Parkinson's Disease Patients
Rolandas Meskys
PLoS ONE
View PDFchevron_right
CSF α-synuclein does not differentiate between parkinsonian disorders
Maqbul Ahmad
Neurobiology of Aging, 2012
View PDFchevron_right
Decrease in Plasma Levels of α-Synuclein Is Evident in Patients with Parkinson's Disease after Elimination of Heterophilic Antibody Interference
Takahiko Tokuda, Omar El-agnaf
PloS one, 2015
View PDFchevron_right